Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Talis Biomedical Corp changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 47 | 45 | −2 |
| Shares | 17.5M | 16.7M | −755.5K (−4.3%) |
| Value | $70.2M | $23.6M | −$46.5M (−66.3%) |
New holders (6)
Institutions that held Talis Biomedical Corp at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 16,598 | $23.0K | 0.00% |
| Barclays PLC | 3,441 | $5.00K | 0.00% |
| FMR LLC | 3,585 | $5.00K | 0.00% |
| Amalgamated Bank | 1,803 | $3.00K | 0.00% |
| Amalgamated Financial Corp. | 1,803 | $3.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 117 | $0 | 0.00% |
Sold out (8)
Institutions that held Talis Biomedical Corp at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| PDT Partners, LLC | 34,890 | $140.0K |
| Citadel Advisors LLC | 34,707 | $139.0K |
| M&T Bank Corp | 13,670 | $55.0K |
| Personal Cfo Solutions, LLC | 10,000 | $40.0K |
| ETF Managers Group, LLC | 7,946 | $32.0K |
| Captrust Financial Advisors | 828 | $3.00K |
| The PNC Financial Services Group, Inc. | 275 | $1.00K |
| Ellevest, Inc. | 41 | $0 |